CervoMed
CRVO
38 hedge funds and large institutions have $59M invested in CervoMed in 2024 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 2 closing their positions.
900% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 2
133% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 3
90% more funds holding
Funds holding: 20 → 38 (+18)
1.03% more ownership
Funds ownership: 40.75% → 41.78% (+1%)
1% more capital invested
Capital invested by funds: $58.6M → $59M (+$427K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$8.34M |
| 2 |
AIC
AWM Investment Company
New York
|
+$6.87M |
| 3 |
BlackRock
New York
|
+$6.17M |
| 4 |
State Street
Boston,
Massachusetts
|
+$1.78M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.74M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
-$3.48M |
| 2 |
AC
Armistice Capital
New York
|
-$2.06M |
| 3 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$972K |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$233K |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$23.1K |
CRVO Hedge Fund Activity: Q2 2024 in Review
38 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in CervoMed (CRVO) for Q2 2024, worth a combined $59M — up 0.73% from $58.6M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new CRVO positions and 2 closed out — a net gain of 18 holders — while 7 added to existing stakes and 3 trimmed.
The largest buyer was Vanguard Group, adding an estimated $8.34M. The largest seller was Adage Capital Partners, cutting an estimated $3.48M.
- 38 institutional investors held CervoMed (CRVO) as of Q2 2024, up from 20 in Q1 2024.
- Funds reported $59M of CervoMed stock for Q2 2024, up 0.73% quarter-over-quarter.
- 20 funds opened new CervoMed positions in Q2 2024 and 2 closed out, a net change of +18 holders.
- The largest CervoMed buyer in Q2 2024 was Vanguard Group, an estimated $8.34M added.
- The largest CervoMed seller in Q2 2024 was Adage Capital Partners, an estimated $3.48M sold.
Based on aggregated 13F filings for Q2 2024.